366 related articles for article (PubMed ID: 17007263)
1. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis].
Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT
Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263
[TBL] [Abstract][Full Text] [Related]
2. Lipoproteins and lipid peroxidation abnormalities in patients with chronic renal disease.
Ong-Ajyooth L; Ong-Ajyooth S; Sirisalee K; Nilwarangkur S
J Med Assoc Thai; 1996 Aug; 79(8):505-12. PubMed ID: 8855633
[TBL] [Abstract][Full Text] [Related]
3. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
4. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism.
Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB
Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709
[TBL] [Abstract][Full Text] [Related]
5. Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment.
Göçmen AY; Sahin E; Koçak H; Tuncer M; Gümüşlü S
Clin Biochem; 2008 Jul; 41(10-11):836-40. PubMed ID: 18457672
[TBL] [Abstract][Full Text] [Related]
6. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
[TBL] [Abstract][Full Text] [Related]
7. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
8. [Lipid profile in maintenance haemodialysis].
Jamoussi K; Ayedi F; Abida N; Kamoun K; Féki H; Chaabouni MN; Hammouda F; Bahloul I; Bellaj A; Hachicha J; Ellouz F
Pathol Biol (Paris); 2005 May; 53(4):217-20. PubMed ID: 15850955
[TBL] [Abstract][Full Text] [Related]
9. Lipoperoxidation and hemodialysis.
Ramos R; Martínez-Castelao A
Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
[TBL] [Abstract][Full Text] [Related]
11. Does ingestion of regular coffee influence serum lipid profile in dialysis patients?
Grzegorzewska AE; Młot-Michalska M; Wobszal P
Adv Perit Dial; 2009; 25():181-6. PubMed ID: 19886342
[TBL] [Abstract][Full Text] [Related]
12. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
13. [Changes in the spectra of lipoproteins and phospholipids in the blood serum of patients with chronic renal failure placed on programmed hemodialysis].
Rozental' RL; Pirogova TF; Zezina LIu
Ter Arkh; 1989; 61(6):99-101. PubMed ID: 2799729
[TBL] [Abstract][Full Text] [Related]
14. Assessment of lipid dysfunction in patients on maintenance haemodialysis.
Altaf A; Halim A; Khan DA; Khalid M; Fatima-Tuz-Zuhra ; Saif I
J Ayub Med Coll Abbottabad; 2007; 19(4):32-6. PubMed ID: 18693593
[TBL] [Abstract][Full Text] [Related]
15. Administration of exogenous erythropoietin beta affects lipid peroxidation and serum paraoxonase-1 activity and concentration in predialysis patients with chronic renal disease and anaemia.
Marsillach J; Martínez-Vea A; Marcas L; Mackness B; Mackness M; Ferré N; Joven J; Camps J
Clin Exp Pharmacol Physiol; 2007 Apr; 34(4):347-9. PubMed ID: 17324148
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress in haemodialysis.
Loughrey CM; Young IS; Lightbody JH; McMaster D; McNamee PT; Trimble ER
QJM; 1994 Nov; 87(11):679-83. PubMed ID: 7820542
[TBL] [Abstract][Full Text] [Related]
17. [Malondialdehyde concentration in the serum of children with chronic renal failure, chronic hemodialysis and kidney transplantation].
Otting U; Hellmann C
Z Urol Nephrol; 1990 Mar; 83(3):141-8. PubMed ID: 2356668
[TBL] [Abstract][Full Text] [Related]
18. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
[TBL] [Abstract][Full Text] [Related]
19. [Lipid status in patients on a chronic hemodialysis program].
Tepsić V; Ristić V; Perunicić G; Rasić Z; Pljesa S; Bokan L; Ranković N
Med Pregl; 1997; 50(1-2):45-7. PubMed ID: 9132551
[TBL] [Abstract][Full Text] [Related]
20. Variable effects of soy protein on plasma lipids in hyperlipidemic and normolipidemic hemodialysis patients.
Chen ST; Ferng SH; Yang CS; Peng SJ; Lee HR; Chen JR
Am J Kidney Dis; 2005 Dec; 46(6):1099-106. PubMed ID: 16310576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
